Navigation Links
Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study
Date:4/18/2013

ccination levels (i.e. levels considered protective in humans or "seroconverted") against the currently circulating H1N1 A/California/07/09 strain. This response rate was comparable to that seen in volunteers who received the matched seasonal influenza vaccine, where 6 of 10 (60%) seroconverted against H1N1 A/California/07/09.

"We couldn't be more pleased with the results from this proof-of-principle and dose-finding study of our H1N1 universal influenza vaccine," said Dr. J. Joseph Kim , Inovio's President and CEO. "We have already demonstrated that we can generate protective antibodies against the important H1N1 strains of the last century using our H1N1 universal vaccine. The new data shows that our universal approach can achieve protection rates comparable to the current seasonal vaccines, which require annual changes to try to match the predicted circulating strains. Collectively, these results further support our mission to develop a universal influenza vaccine capable of providing years of true preemptive protection across subtypes and strains. These results add significantly to the advancement of our seasonal universal flu vaccine program. They will also help fine-tune dosing for our pandemic avian H5N1 program and support our research for the new H7N9 subtype that has emerged even more rapidly than H5N1."

Inovio previously reported interim results from this phase I study showing that its SynCon® universal H1N1 influenza vaccine generated protective HAI titers against some of the most prevalent strains of H1N1 influenza from the past 100 years. The vaccine recipients from this study generated protective HAI responses against the H1N1 A/South Carolina/1/18 strain (so-called 1918 Spanish flu) as well as all the H1N1 strains that were part of the seasonal trivalent inactivated flu vaccines (TIV) since 1986, including: A/Taiw
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
2. Inovio Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Inovio Pharmaceuticals to Present at SPI 2012
4. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
5. Inovio Pharmaceuticals to Present at JMP Investor Conference
6. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
7. Inovio Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on August 2nd
8. Inovio Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
9. Inovio Pharmaceuticals Reports 2012 Second Quarter Financial Results
10. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
11. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 2015  Daiichi Sankyo, Inc., the US subsidiary of ... merge with its US-based sister company, Asubio Pharmaceuticals, Inc.  ... integrated into the Daiichi Sankyo global development organization, led ... Asubio Pharmaceuticals, parent company, Asubio Pharma Co., Ltd, ... will continue to operate as a wholly owned subsidiary ...
(Date:4/1/2015)... and MENLO PARK, Calif. , ... (OTCQX: DMPI) ("DelMar" and the "Company"), today announced ... Mohr , Ph.D., R.Psych., to its Board of Directors ... close to two decades of biotechnology experience in executive ... officer and board member, including serving as the chairman ...
(Date:4/1/2015)... Minn. , April 1, 2015  EnteroMedics ... devices using neuroblocking technology to treat obesity, metabolic ... the Company has entered into a partnership with ... access to vBloc® Therapy, delivered via the Maestro® ... System is approved for adults with a BMI ...
Breaking Medicine Technology:Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge 2DelMar Pharmaceuticals Appoints Biopharmaceutical Industry Veteran, Erich Mohr, Ph.D., R.Psych., to the Board of Directors 2DelMar Pharmaceuticals Appoints Biopharmaceutical Industry Veteran, Erich Mohr, Ph.D., R.Psych., to the Board of Directors 3DelMar Pharmaceuticals Appoints Biopharmaceutical Industry Veteran, Erich Mohr, Ph.D., R.Psych., to the Board of Directors 4EnteroMedics Announces Partnership with American HealthCare Lending to Support Patient Access and Enhance Affordability of vBloc Therapy 2EnteroMedics Announces Partnership with American HealthCare Lending to Support Patient Access and Enhance Affordability of vBloc Therapy 3EnteroMedics Announces Partnership with American HealthCare Lending to Support Patient Access and Enhance Affordability of vBloc Therapy 4
... BALTIMORE, April 24, 2012   The University of Maryland ... Vice President of Research and Development at MedImmune ... the UM Health Sciences Research Park Corporation (RPC) ... ) "The BioPark leadership team is ...
... Simcere Pharmaceutical Group (NYSE: SCR ), a ... marketing of branded generic and proprietary pharmaceuticals in China, ... results for the first quarter ended March 31, 2012 ... in the United States. Simcere,s management will host an ...
Cached Medicine Technology:University of Maryland BioPark Announces MedImmune's Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park 2University of Maryland BioPark Announces MedImmune's Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park 3Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012 2
(Date:4/1/2015)... Enterprise Integration has appeared on ... distinguished list and report identifying the world’s top ... list is currently available on the MSPmentor. Additional ... MSPs in North America ,     The top ...     The top MSPs in Asia, Australia and ...
(Date:3/31/2015)... Bon Secours New York Health System ... Nursing Care Center family last week. The Sisters formerly ... Yonkers which is scheduled to close later this year. ... the Sisters of Charity of New York, the decision ... place their Sisters at Schervier Nursing Care Center followed ...
(Date:3/31/2015)... On November 24, 2014, Per Wickstrom had an opportunity ... problem of substance abuse and the solutions that are offered ... and recovery, gives a unique first-person perspective on addiction and ... the New York Giants, Taylor’s early career was almost cut ... he was able to straighten out long enough to make ...
(Date:3/31/2015)... 31, 2015 Over the last several ... technique have yielded better results and more efficient ... and perfected by a good hair transplant surgeon, has ... techniques of hair restoration have improved the efficiency of ... used to add precision and flexibility to the field ...
(Date:3/31/2015)... Dr. Parsa Mohebi, founder of Parsa Mohebi Hair Restoration has ... of using beard hair to fill in balding areas ... has now become an absolute option for giving patients the best ... believe that beard to scalp hair transplant can be a patients ... as dense as we would like it,” says Dr. Parsa Mohebi. ...
Breaking Medicine News(10 mins):Health News:Penton Technology Names Enterprise Integration to the MSPmentor 501 Global Edition 2Health News:Penton Technology Names Enterprise Integration to the MSPmentor 501 Global Edition 3Health News:Bon Secours New York Health System Welcomes Retired Sisters of Charity to the Family 2Health News:Lawrence Taylor & Per Wickstrom Discuss the Drug Rehabilitation & Recovery Process 2Health News:Beverly Hills Hair Transplant Surgeon Now Combines Advanced Robotic Hair Transplantation and Manual Techniques for Greatest Results 2Health News:Is Beard to Scalp Hair Transplant the Future? 2
... researchers have found that Diethanolamine (DEA), an ingredient found ... to interfere with normal brain development in baby mice. ... mice and seemed to have an adverse effect on ... Professor of nutrition in UNC's schools of public health ...
... a tumor suppressor gene which was identified by Professor Sir ... done on this gene using the mice model shows that ... ageing process. Larry Donehower of Baylor College of Medicine in ... they later developed cancer. In another set he modified the ...
... the fatty acid ratio found in the typical Western diet ... of omega-6 fatty acids// may reduce prostate cancer tumor growth ... issue of the journal Clinical Cancer Research, this initial animal-model ... of diet on lowering an inflammatory response known to promote ...
... Evaluation of bone healing can be primarily dome ... formatting as the primary imaging// technique, according to ... University of Vienna in Vienna, Austria. ... fusion) or spinal fusions who'd undergone MDCT and ...
... the Earth Institute, Columbia University, a well-known economist feels ... Schemes// in order to provide better healthcare facilities for ... Mission, India should make a National Health Insurance scheme ... population of the country still living in poverty" he ...
... Farma, the country's biggest vaccine producer, has been awarded a ... Indonesian government.// ,The Agricultural Ministry awarded the ... billion rupiah (US$1.01 million) was the lowest among the bidding ... from China, which could begin within two weeks after the ...
Cached Medicine News:Health News:Altering Fatty Acid Levels in Diet May Reduce Prostate Cancer Growth Rate 2
Inquire...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
... either EDTA K2 or EDTA K3 ... and therefore blocks the coagulation cascade. ... EDTA anticoagulated blood sample are stable ... tubes are for the examination of ...
Glass Whole Blood Tube with K3EDTA...
Medicine Products: